3i to sell Belgian chemicals distributor Azelis

Published: 30-Mar-2011
Finance

Bank of America Merrill Lynch has been hired to facilitate sale


Private equity firm 3i is reported to have kicked off the sale of Belgian chemicals distributor Azelis and has hired Bank of America Merrill Lynch to sell the company on its behalf.

3i acquired Azelis in 2007 in a deal worth €315m and the chemicals company has recently turned over €1bn. Sources for 3i have declined to comment.

Azelis operates in 26 markets across Europe and has offices in Shanghai and Mumbai serving more than 50,000 with chemicals for paints and polymers for plastics manufacture.
  • Companies:
  • Azelis Group
See more

You may also like

Finance

Azelis acquires South Korean surfactant distributor

Read more
The Coseal acquisition is hoped to drive further growth for the company across Asia Pacific

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region
  2. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  3. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance
  4. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
  5. £20m Scottish oligonucleotide manufacturing innovation centre now under construction The centre will act as an innovation centre, assisting in the development and optimisation of oligonucleotide manufacturing processes, while also bolstering the UK's biopharmaceutical presence

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Finance

Azelis acquires South Korean surfactant distributor

The Coseal acquisition is hoped to drive further growth for the company across Asia Pacific
Research & Development

Azelis opens application and training center in Istanbul

It will also host customer meetings, interactive formulation workshops, supplier meetings and internal technical trainings
Ingredients

Azelis completes Megafarma acquisition in Mexico

Megafarma is a premier speciality chemicals and food ingredient distributor
Ingredients

Azelis to acquire Turkish specialty chemicals distributor Ekin Kimya

The Istanbul-based company supplies chemicals for pharma, food ingredients and laboratory applications
Ingredients

Azelis gains a leading position in Australia and NZ with acquisition of Chemcolour

Azelis has agreed to fully acquire Chemcolour, a leading provider of specialty chemicals and food ingredients in Australia and New Zealand (ANZ)
Ingredients

Azelis to acquire S&D Group

Deal will strengthen life science business in terms of product coverage and geographical spread
Ingredients

Azelis to unite its 36 companies into one brand

European speciality chemicals distributor rebrands
Subscribe now